Biosyntrx Launches Superior Fish-Oil Product

17/10/05 Biosyntrx, an evidence-based company providing nutraceutical products that support the eye and body health today announced the launch of their new product, ZoOmega-3, a high-quality concentrated Omega-3 dietary supplement from cold-water fish.

Cold-water fish contain essential fatty acids suggested to play an important role in eye and body health and disease prevention. Each capsule of ZoOmega-3 contains 300 mg of ethyl EPA Omega-3 fatty acid suggested to appropriately inhibit the downstream metabolism of Omega 6 fatty acids, preventing excessive production of pro-inflammatory prostaglandins, which have been suggested in the literature to contribute to silent inflammation when not kept in check.

Each capsule of ZoOmega-3 also includes 200 mg of ethyl DHA, another Omega-3 fatty acid, suggested to increase cellular permeability allowing nutrients such as, amino acids, antioxidants, enzymes, vitamins and minerals to enter cells to address free radical damage and oxidation, as well as to protect mitochondria DNA.

Spencer Thornton, MD, president, chief medical officer, and one of the Biosyntrx founders, commented, "Excessive amounts of Omega-3 fatty acid can interfere with the body's ability to mount a lifesaving inflammatory response when needed, such as fevers to combat viral or bacterial attack, swelling to protect broken bones, or clotting to stop bleeding. Therefore we recommend one capsule of our high-quality ZoOmega-3 a day for health maintenance and disease prevention, particularly on days that fish is not included in the diet.

ZoOmega-3 is manufactured to meet current Good Manufacturing Practices (cGMP). It is cholesterol and triglyceride free and contains no discernible amount of mercury or PCBs.